HighTower Advisors »

Briacell Therapeutics Corp shares owned by HighTower Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 15k 1.09
2024-03-31 $41k 15k 2.84
2023-12-31 $93k 16k 5.85
2023-09-30 $99k 16k 6.23

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Summit Trail Advisors
LPL Financial
Cambridge Investment Research Advisors
HighTower Advisors
Concord Wealth Partners
Susquehanna International
National Bank Of Canada /fi/
Royal Bank of Canada
TD Waterhouse Canada

View all funds holding Briacell Therapeutics Corp